X-74740848-T-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001008537.3(NEXMIF):c.3709A>T(p.Met1237Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000652 in 1,210,938 control chromosomes in the GnomAD database, including 3 homozygotes. There are 204 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001008537.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.3709A>T | p.Met1237Leu | missense_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.3709A>T | p.Met1237Leu | missense_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682 | P1 | |
NEXMIF | ENST00000616200.2 | c.3709A>T | p.Met1237Leu | missense_variant | 3/5 | 1 | ENSP00000480284 | P1 | ||
NEXMIF | ENST00000642681.2 | c.3709A>T | p.Met1237Leu | missense_variant | 3/3 | ENSP00000495800 |
Frequencies
GnomAD3 genomes AF: 0.00341 AC: 384AN: 112751Hom.: 2 Cov.: 23 AF XY: 0.00304 AC XY: 106AN XY: 34893
GnomAD3 exomes AF: 0.000961 AC: 176AN: 183057Hom.: 1 AF XY: 0.000518 AC XY: 35AN XY: 67587
GnomAD4 exome AF: 0.000370 AC: 406AN: 1098132Hom.: 1 Cov.: 32 AF XY: 0.000275 AC XY: 100AN XY: 363508
GnomAD4 genome AF: 0.00340 AC: 383AN: 112806Hom.: 2 Cov.: 23 AF XY: 0.00298 AC XY: 104AN XY: 34958
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 13, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
X-linked intellectual disability, Cantagrel type Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 24, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at